Microwave ablation for liver tumours
Vandepeer M, Forel D, Nicolopoulos K, Rochet E, Ali A, Duncan J, Goetz G
Record ID 32018002666
Authors' objectives: Microwave ablation (MWA) uses electromagnetic energy to heat and destroy tumours. It is used under local or general anaesthesia, either percutaneously, laparoscopically or as part of open surgery for primary hepatocellular (HCC), but also secondary liver carcinomas.
Authors' results and conclusions: Given the available evidence (12 RCTs), MWA appears to be comparable to radiofrequency ablation (RFA) for the treatment of early-stage HCC.
Authors' recommendations: Further clinical trials and robust RCTs are needed to evaluate the efficacy and safety of MWA compared to other treatments for early-stage HCC, as well as the use of MWA to treat other types of primary and secondary liver cancer.
Project Status: Completed
Year Published: 2022
URL for published report: https://eprints.aihta.at/1391/1/DSD_131.pdf
URL for additional information: https://eprints.aihta.at/1391
English language abstract: An English language summary is available
Publication Type: Full HTA
- Liver Neoplasms
- Ablation Techniques
- Carcinoma, Hepatocellular
- Catheter Ablation
- Liver cancer
- hepatocellular carcinoma
- minimally-invasive surgery
- microwave ablation
- thermic ablation
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Garnisongasse 7/20, A-1090 Vienna, Austria
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: HTA Austria - AIHTA GmbH
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.